{"schema_version":"1","generated_at":"2026-11-06T23:21:06.183Z","data_as_of":null,"url":"https://www.findmykol.com/kol/sima-bhatt","json_url":"https://www.findmykol.com/kol/sima-bhatt/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"sima-bhatt","name":"Sima Bhatt","credential":"MD","specialty":"Pediatric Hematology-Oncology","specialty_raw":"Pediatric Hematology-Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Disc Medicine","institution_url":"https://www.findmykol.com/institution/disc-medicine","city":"Saint Louis","state":"MO","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1487965679","orcid":"0000-0001-6751-5808","openalex":"A5053436400"},"summary":"Sima Bhatt is an Oncology physician affiliated with Disc Medicine. OpenAlex indexes 33 publications with 500 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":33,"cited_by_count":500,"h_index":10,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"Novartis","program_year":2024,"amount_usd":206.55,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487965679"},{"payer":"Novartis","program_year":2023,"amount_usd":275.4,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487965679"},{"payer":"Novartis","program_year":2022,"amount_usd":2675.76,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1487965679"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1487965679","source":"payments"},"publications":{"total":33,"shown":5,"withheld":28,"matched_by":"OpenAlex author record","recent":[{"title":"Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of Immunity","year":2025,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.11.028","status":"verified"},{"title":"RALLY MF: A phase 2 Study of DISC-0974, an anti-hemojuvelin antibody, in patients with myelofibrosis and anemia","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-2042","status":"verified"},{"title":"MPN-757: A Phase 1b Trial of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients With Myelofibrosis and Anemia","year":2025,"journal":"Clinical Lymphoma Myeloma & Leukemia","source_url":"https://doi.org/10.1016/s2152-2650(25)02138-x","status":"verified"},{"title":"Alemtuzumab, Fludarabine, Melphalan, and Thiotepa As a Reduced-Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in Inborn Errors of Immunity","year":2025,"journal":"Transplantation and Cellular Therapy","source_url":"https://doi.org/10.1016/j.jtct.2025.01.272","status":"verified"},{"title":"A Phase 1b, Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Nondialysis-Dependent CKD and Anemia","year":2025,"journal":"Journal of the American Society of Nephrology","source_url":"https://doi.org/10.1681/asn.2025xwmvyjap","status":"verified"}],"source":"works"},"contact":{"address_1":"1 CHILDRENS PL","address_2":"DIV PED HEMATOLOGY & ONC, STE 9S","city":"Saint Louis","state":"MO","zip":"631101002","phone":"314-454-6018","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1487965679","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":28}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-11-15","provider_certified":"2020-03-05","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}